Fidelity Investments’s Evelo Biosciences, Inc. Common Stock EVLO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-2,446,390
| Closed | -$9.59M | – | 5770 |
|
|
2023
Q3 | $9.59M | Buy |
2,446,390
+2,319,965
| +1,835% | +$15.8M | ﹤0.01% | 1838 |
|
|
2023
Q2 | $411K | Sell |
126,425
-683,429
| -84% | -$2.03M | ﹤0.01% | 2720 |
|
|
2023
Q1 | $2.93M | Sell |
809,854
-11,564
| -1% | -$179K | ﹤0.01% | 2263 |
|
|
2022
Q4 | $26.4M | Buy |
821,418
+11,465
| +1% | +$454K | ﹤0.01% | 1503 |
|
|
2022
Q3 | $33.9M | Buy |
809,953
+668
| +0.1% | +$30.5K | ﹤0.01% | 1401 |
|
|
2022
Q2 | $34.2M | Buy |
809,285
+406,961
| +101% | +$18.9M | ﹤0.01% | 1427 |
|
|
2022
Q1 | $27.3M | Buy |
402,324
+1,374
| +0.3% | +$114K | ﹤0.01% | 1647 |
|
|
2021
Q4 | $48.7M | Buy |
400,950
+463
| +0.1% | +$78.2K | ﹤0.01% | 1431 |
|
|
2021
Q3 | $56.4M | Buy |
400,487
+183
| +0% | +$36.3K | ﹤0.01% | 1362 |
|
|
2021
Q2 | $110M | Buy |
400,304
+292
| +0.1% | +$73.7K | 0.01% | 1087 |
|
|
2021
Q1 | $85.6M | Buy |
400,012
+59,844
| +18% | +$16.5M | 0.01% | 1137 |
|
|
2020
Q4 | $82.3M | Buy |
340,168
+90,119
| +36% | +$11.1M | 0.01% | 1120 |
|
|
2020
Q3 | $26.4M | Buy |
250,049
+22,488
| +10% | +$2.05M | ﹤0.01% | 1450 |
|
|
2020
Q2 | $22.3M | Buy |
227,561
+66,518
| +41% | +$5.82M | ﹤0.01% | 1505 |
|
|
2020
Q1 | $12.1M | Sell |
161,043
-1,078
| -0.7% | -$103K | ﹤0.01% | 1633 |
|
|
2019
Q4 | $13.2M | Sell |
162,121
-3,377
| -2% | -$378K | ﹤0.01% | 1748 |
|
|
2019
Q3 | $20.2M | Sell |
165,498
-2,885
| -2% | -$397K | ﹤0.01% | 1571 |
|
|
2019
Q2 | $30.2M | Buy |
168,383
+2,128
| +1% | +$344K | ﹤0.01% | 1447 |
|
|
2019
Q1 | $26.6M | Buy |
166,255
+955
| +0.6% | +$189K | ﹤0.01% | 1462 |
|
|
2018
Q4 | $43M | Buy |
165,300
+2,055
| +1% | +$414K | 0.01% | 1210 |
|
|
2018
Q3 | $38.6M | Sell |
163,245
-2,310
| -1% | -$605K | ﹤0.01% | 1394 |
|
|
2018
Q2 | $36.8M | Buy |
+165,555
| New | +$48.3M | ﹤0.01% | 1430 |
|
Other funds holding EVLO
Fidelity Investments's EVLO Position: Q4 2023 in Review
Fidelity Investments sold out of Evelo Biosciences, Inc. Common Stock (EVLO) in Q4 2023, closing a stake of 2,446,390 shares — an estimated $9.59M sold.
Fidelity Investments first reported a position in EVLO in Q2 2018 and held it in 22 quarters. The position peaked at $110M in Q2 2021. 2 funds tracked by Wall St. Rank hold EVLO as of Q4 2023.
- Fidelity Investments reported no remaining Evelo Biosciences, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
- Fidelity Investments sold 2,446,390 Evelo Biosciences, Inc. Common Stock shares in Q4 2023, an estimated $9.59M.
- Fidelity Investments first reported a position in Evelo Biosciences, Inc. Common Stock in Q2 2018 and held it in 22 quarters.
- Fidelity Investments's Evelo Biosciences, Inc. Common Stock position peaked at $110M in Q2 2021.
- 2 funds tracked by Wall St. Rank held Evelo Biosciences, Inc. Common Stock as of Q4 2023.
Based on Fidelity Investments's 13F filing for Q4 2023, filed 13 Feb 2024.